Therapeutic benefits
10 minute read
Elevating CBD Safety Standards: A Roadmap for Regulators
Introduction The increasing popularity and availability of cannabidiol (CBD) products has raised concerns regarding their safety, quality control, and regulatory oversight. CBD, a non-psychoactive compound derived from cannabis plants, has gained...
Filter
Filter
Results - 215 Blogs
The cannabis industry has been on an unprecedented journey in recent years. This has been led by a...
Today, the UK Department of Health and Social Care (DHSC) published a white paper, “Stopping the...
The Cannabis Science Conference (CSC) takes place twice a year on the east and west coast of the...
4 minute read
Is CBD Psychoactive?
To celebrate National CBD Day in the U.S. on August 8th, Alberto Sainz, Principle Scientist – Human...
4 minute read
PSYCH Symposium 2023
Broughton’s Chief Scientific and Regulatory Officer, Dr. Nveed Chaudhary, recently attended the...
2 minute read
Broughton Launches E&L Testing Service
Broughton expands analytical testing services with a one-stop solution for Extractables and...
2 minute read
ENDS Europe Conference
Broughton’s Managing Consultant for Product Realization, Pete Lomas, shares his thoughts from the...
6 minute read
Next Gen Nicotine Delivery 2023
This year's Next Generation Nicotine Delivery USA Conference brought many of the same challenges as...
Sign up to our newsletter
Ensure your business stays ahead of the competition by keeping up to date on the latest regulatory changes. Sign up for our newsletter to have the latest information and insights served directly to your inbox.